One of the oldest pharmaceutical companies in the Baltic states
Specializing in generics mostly for the hospital segment
Key products: life–saving medicines, especially in the CNS and cardiovascular therapeutic group
The company complies with the EU GMP requirements.
JSC Kalceks launches Hydromorphone Kalceks 2, 10, 20 and 50 mg/ml solution for injections/infusions
JSC Kalceks starts production and commercialization of Hydromorphone Kalceks 2, 10, 20 and 50 mg/ml solution for injections/infusions. Product has been registered via decentralized registration procedure involving 10 European Union countries.
First sales are expected in Germany and Netherlands following by other EU countries. Hydromorphone Kalceks 2, 10, 20 and 50 mg/ml solution for injections/infusions is a third new product that Kalceks launches within this year.
|